People with advanced or metastatic urothelial cancer will soon have access to a new treatment option following a NICE recommendation.Original Article
You may also like
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.